Skip to main content
Top
Published in: BMC Hematology 1/2015

Open Access 01-12-2015 | Research article

Decreased erythrocyte nucleoside transport and hENT1 transporter expression in glucose 6-phosphate dehydrogenase deficiency

Authors: Mohammad Al-Ansari, James D. Craik

Published in: BMC Hematology | Issue 1/2015

Login to get access

Abstract

Background

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with erythrocyte sensitivity to oxidative damage and hemolytic crises. In β-thalassemia major, where hemoglobin instability imposes oxidative stress, erythrocytes show reduced hENT1 nucleoside transporter expression and decreased nucleoside uptake. This study investigated hENT1 expression and nucleoside transport in G6PD-deficient erythrocytes to determine if decreased hENT1 activity might be a contributory feature in the variable pathology of this enzymopathy.

Methods

Uptake of 3H-uridine was measured at room temperature using an inhibitor-oil stop protocol and 5-s incubations. Erythrocyte membranes were analyzed by SDS-PAGE and nucleoside (hENT1), glucose (GLUT-1), and anion exchange (Band 3) transporter polypeptides quantitated on immunoblots.

Results

In G6PD-deficient cells, uridine uptake (mean 8.18, 95 % CI 5.6–10.7 vs controls mean 12.35, 95 % CI 9.2–15.5, pmol uridine/gHb/min; P = 0.031) and expression of hENT1 (mean 50.4 %, 95 % CI 38.1–62.7 %, arbitrary units n = 11 vs controls mean 95.23 %, 95 % CI 88.38–102.1 % arbitrary units, n = 8; P < 0.001) were significantly lower; expression of GLUT-1 (mean 106.9 %, vs control mean 99.75 %; P = 0.308) and Band 3 polypeptides (mean 100.1 %, vs control mean 102.84 %; P = 0.329) were unchanged.

Conclusions

Nucleoside transporter activity in human erythrocytes sustains intracellular purine nucleotide levels and assists in control of plasma adenosine levels; decreased hENT1 expression and activity in G6PD-deficiency could affect red metabolism and influence a wide spectrum of responses mediated by adenosine receptors.
Literature
1.
go back to reference Nkhoma ET, Poole C, Vannappagari V, Hall SA, Buetler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267–78.CrossRefPubMed Nkhoma ET, Poole C, Vannappagari V, Hall SA, Buetler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267–78.CrossRefPubMed
2.
go back to reference Capellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64–74.CrossRef Capellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64–74.CrossRef
3.
go back to reference Beutler E, Vulliamy TJ. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis. 2002;28:93–103.CrossRefPubMed Beutler E, Vulliamy TJ. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis. 2002;28:93–103.CrossRefPubMed
4.
go back to reference Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood Cells Mol Dis. 2012;48:154–65.CrossRefPubMed Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood Cells Mol Dis. 2012;48:154–65.CrossRefPubMed
5.
go back to reference Haldane JBS. The rate of mutation of human genes. Hereditas Suppl. 1949;35:267–73.CrossRef Haldane JBS. The rate of mutation of human genes. Hereditas Suppl. 1949;35:267–73.CrossRef
6.
go back to reference López C, Saravia C, Gomez A, Hoebeke J, Patarroyo MA. Mechanisms of genetically-based resistance to malaria. Gene. 2010;467:1–12.CrossRefPubMed López C, Saravia C, Gomez A, Hoebeke J, Patarroyo MA. Mechanisms of genetically-based resistance to malaria. Gene. 2010;467:1–12.CrossRefPubMed
7.
go back to reference Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007;21:267–83.CrossRefPubMed Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007;21:267–83.CrossRefPubMed
8.
go back to reference Beutler E. G6PD deficiency. Blood. 1994;84:613–36. Beutler E. G6PD deficiency. Blood. 1994;84:613–36.
9.
go back to reference Peters AL, Van Noorden CJ. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem. 2009;57:1003–11.CrossRefPubMedPubMedCentral Peters AL, Van Noorden CJ. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem. 2009;57:1003–11.CrossRefPubMedPubMedCentral
11.
go back to reference Luzzatto L. G6PD deficiency and malaria selection. Heredity (Edinb). 2012;108:456.CrossRef Luzzatto L. G6PD deficiency and malaria selection. Heredity (Edinb). 2012;108:456.CrossRef
12.
go back to reference Jollow DJ, McMillan DC. Oxidative stress, glucose-6-phosphate dehydrogenase and the red cell. Adv Exp Med Biol. 2001;500:595–605.CrossRefPubMed Jollow DJ, McMillan DC. Oxidative stress, glucose-6-phosphate dehydrogenase and the red cell. Adv Exp Med Biol. 2001;500:595–605.CrossRefPubMed
14.
go back to reference Stamatoyannopoulos G, Fraser GR, Motulsky AC, Fessas P, Akrivakis A, Papayannopoulou T. On the familial predisposition to favism. Am J Hum Genet. 1966;18:253–63.PubMedPubMedCentral Stamatoyannopoulos G, Fraser GR, Motulsky AC, Fessas P, Akrivakis A, Papayannopoulou T. On the familial predisposition to favism. Am J Hum Genet. 1966;18:253–63.PubMedPubMedCentral
15.
go back to reference Maren C, Repetto L, Forteloni G, Meloni T, Gaetani GF. Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency. J Med Genet. 1984;21:278–80.CrossRef Maren C, Repetto L, Forteloni G, Meloni T, Gaetani GF. Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency. J Med Genet. 1984;21:278–80.CrossRef
16.
go back to reference Parks Jr RE, Crabtree GW, Kong CW, Agarwal RP, Agarwal KC, Scholar EM. Incorporation of analog purine nucleosides into the formed elements of human blood: erythrocytes, platelets and lymphocytes. Ann N Y Acad Sci. 1975;255:412–34.CrossRefPubMed Parks Jr RE, Crabtree GW, Kong CW, Agarwal RP, Agarwal KC, Scholar EM. Incorporation of analog purine nucleosides into the formed elements of human blood: erythrocytes, platelets and lymphocytes. Ann N Y Acad Sci. 1975;255:412–34.CrossRefPubMed
17.
go back to reference Dudzinska W, Lubkowska A, Dolegowska B, Safranow K, Jakubowska K. Adenine, guanine and pyridine nucleotides in blood during physical exercise and restitution in healthy subjects. Eur J Appl Physiol. 2010;110:1155–62.CrossRefPubMedPubMedCentral Dudzinska W, Lubkowska A, Dolegowska B, Safranow K, Jakubowska K. Adenine, guanine and pyridine nucleotides in blood during physical exercise and restitution in healthy subjects. Eur J Appl Physiol. 2010;110:1155–62.CrossRefPubMedPubMedCentral
18.
go back to reference King AE, Ackley MA, Cass CE, Young JD, Baldwin SA. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci. 2006;27:416–25.CrossRefPubMed King AE, Ackley MA, Cass CE, Young JD, Baldwin SA. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci. 2006;27:416–25.CrossRefPubMed
19.
go back to reference Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 2004;447:735–43.CrossRefPubMed Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 2004;447:735–43.CrossRefPubMed
20.
go back to reference Young JD, Yao SYM, Sun I, Cass CE, Baldwin SA. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica. 2008;38:995–1021.CrossRefPubMed Young JD, Yao SYM, Sun I, Cass CE, Baldwin SA. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica. 2008;38:995–1021.CrossRefPubMed
21.
go back to reference Yao SY, Ng AM, Cass CE, Baldwin SA, Young JD. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1). J Biol Chem. 2011;286:32552–62.CrossRefPubMedPubMedCentral Yao SY, Ng AM, Cass CE, Baldwin SA, Young JD. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1). J Biol Chem. 2011;286:32552–62.CrossRefPubMedPubMedCentral
22.
go back to reference Zeidler RB, Metzler MH, Moran JB, Kim HD. The liver is an organ site for the release of inosine metabolized by non-glycolytic pig red cells. Biochim Biophys Acta. 1985;838:321–8.CrossRefPubMed Zeidler RB, Metzler MH, Moran JB, Kim HD. The liver is an organ site for the release of inosine metabolized by non-glycolytic pig red cells. Biochim Biophys Acta. 1985;838:321–8.CrossRefPubMed
23.
go back to reference Young J, Paterson AR, Henderson JF. Nucleoside transport and metabolism in erythrocytes from the Yucatan miniature pig. Evidence that inosine functions as an in vivo energy substrate. Biochim Biophys Acta. 1985;842:214–24.CrossRefPubMed Young J, Paterson AR, Henderson JF. Nucleoside transport and metabolism in erythrocytes from the Yucatan miniature pig. Evidence that inosine functions as an in vivo energy substrate. Biochim Biophys Acta. 1985;842:214–24.CrossRefPubMed
25.
go back to reference Gero AM, Wood AM, Hogue DL, Upston JM. Effect of diamide on nucleoside transport in Plasmodium falciparum and Babesia bovis infected erythrocytes. Mol Biochem Parasitol. 1991;44:195–206.CrossRefPubMed Gero AM, Wood AM, Hogue DL, Upston JM. Effect of diamide on nucleoside transport in Plasmodium falciparum and Babesia bovis infected erythrocytes. Mol Biochem Parasitol. 1991;44:195–206.CrossRefPubMed
26.
go back to reference Myint-Oo O'SWJ, Gero AM. Laboratory and field comparisons of adenosine influx in Plasmodium falciparum and Plasmodium vivax infected erythrocytes with genetic abnormalities from patients in Myanmar. Southeast Asian J Trop Med Public Health. 1997;28:22–31.PubMed Myint-Oo O'SWJ, Gero AM. Laboratory and field comparisons of adenosine influx in Plasmodium falciparum and Plasmodium vivax infected erythrocytes with genetic abnormalities from patients in Myanmar. Southeast Asian J Trop Med Public Health. 1997;28:22–31.PubMed
27.
go back to reference Al-Massaeid AL, Craik JD. Decreased nucleoside transport and hENT1 transporter expression in beta-thalassemia major. Med Princ Pract. 2009;18:180–6.CrossRefPubMed Al-Massaeid AL, Craik JD. Decreased nucleoside transport and hENT1 transporter expression in beta-thalassemia major. Med Princ Pract. 2009;18:180–6.CrossRefPubMed
28.
go back to reference Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.PubMed
29.
go back to reference Jennings LL, Hao C, Cabrita MA, Vickers MF, Baldwin SA, Young JD, et al. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology. 2001;40:722–31.CrossRefPubMed Jennings LL, Hao C, Cabrita MA, Vickers MF, Baldwin SA, Young JD, et al. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology. 2001;40:722–31.CrossRefPubMed
30.
go back to reference Samilchuk E, D'Souza B, Al-Awadi S. Population study of common glucose-6-phosphate dehydrogenase mutations in Kuwait. Hum Hered. 1999;49:41–4.CrossRefPubMed Samilchuk E, D'Souza B, Al-Awadi S. Population study of common glucose-6-phosphate dehydrogenase mutations in Kuwait. Hum Hered. 1999;49:41–4.CrossRefPubMed
31.
go back to reference Alfadhli S, Kaaba S, Elshafey A, Salim M, AlAwadi A, Bastaki L. Molecular characterization of glucose-6-phosphate dehydrogenase gene defect in the Kuwaiti population. Arch Pathol Lab Med. 2005;129:1144–7.PubMed Alfadhli S, Kaaba S, Elshafey A, Salim M, AlAwadi A, Bastaki L. Molecular characterization of glucose-6-phosphate dehydrogenase gene defect in the Kuwaiti population. Arch Pathol Lab Med. 2005;129:1144–7.PubMed
32.
go back to reference Cassera MB, Zhang Y, Hazleton KZ, Schramm VL. Purine and pyrimidine pathways as targets in Plasmodium falciparum. Curr Top Med Chem. 2011;11:2103–15.CrossRefPubMedPubMedCentral Cassera MB, Zhang Y, Hazleton KZ, Schramm VL. Purine and pyrimidine pathways as targets in Plasmodium falciparum. Curr Top Med Chem. 2011;11:2103–15.CrossRefPubMedPubMedCentral
33.
go back to reference Quashie NB, Ranford-Cartwright LC, de Koning HP. Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter. Malar J. 2010;9:36–46.CrossRefPubMedPubMedCentral Quashie NB, Ranford-Cartwright LC, de Koning HP. Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter. Malar J. 2010;9:36–46.CrossRefPubMedPubMedCentral
34.
go back to reference Preuss J, Jortzik E, Becker K. Glucose-6-phosphate metabolism in Plasmodium falciparum. IUBMB Life. 2012;64:603–11.CrossRefPubMed Preuss J, Jortzik E, Becker K. Glucose-6-phosphate metabolism in Plasmodium falciparum. IUBMB Life. 2012;64:603–11.CrossRefPubMed
35.
go back to reference Zhang Y, Dai Y, Wen J, Zhang W, Grenz A, Sun H, et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat Med. 2011;17:79–86.CrossRefPubMed Zhang Y, Dai Y, Wen J, Zhang W, Grenz A, Sun H, et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat Med. 2011;17:79–86.CrossRefPubMed
Metadata
Title
Decreased erythrocyte nucleoside transport and hENT1 transporter expression in glucose 6-phosphate dehydrogenase deficiency
Authors
Mohammad Al-Ansari
James D. Craik
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Hematology / Issue 1/2015
Electronic ISSN: 2052-1839
DOI
https://doi.org/10.1186/s12878-015-0038-0

Other articles of this Issue 1/2015

BMC Hematology 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.